These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3814933)

  • 21. Changes in internal states across the binge-vomit cycle in bulimia nervosa.
    Corstorphine E; Waller G; Ohanian V; Baker M
    J Nerv Ment Dis; 2006 Jun; 194(6):446-9. PubMed ID: 16772863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bulimia nervosa: group behavior therapy with exposure plus response prevention.
    Gray JJ; Hoage CM
    Psychol Rep; 1990 Apr; 66(2):667-74. PubMed ID: 1971954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eating behavior following stress in women with and without bulimic symptoms.
    Levine MD; Marcus MD
    Ann Behav Med; 1997; 19(2):132-8. PubMed ID: 9603688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relatively enriched housing conditions delay binge onset but do not attenuate binge size.
    Preston KE; Corwin RL; Bader JO; Crimmins SL
    Physiol Behav; 2018 Feb; 184():196-204. PubMed ID: 29155246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bulimia: symptoms and syndromes in an urban population.
    Ben-Tovim DI; Subbiah N; Scheutz B; Morton J
    Aust N Z J Psychiatry; 1989 Mar; 23(1):73-80. PubMed ID: 2784668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine.
    Kennedy SH; Goldbloom DS; Ralevski E; Davis C; D'Souza JD; Lofchy J
    J Clin Psychopharmacol; 1993 Dec; 13(6):415-22. PubMed ID: 8120155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exposure plus prevention of bingeing vs. exposure plus prevention of vomiting in bulimia nervosa. A crossover study.
    Schmidt U; Marks IM
    J Nerv Ment Dis; 1989 May; 177(5):259-66. PubMed ID: 2708970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Everyday addictive behavior of bulimic women.
    Jäger B; Liedtke R; Künsebeck HW; Seide L; Lempa W
    Psychother Psychosom; 1991; 56(1-2):64-9. PubMed ID: 1891583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal caloric requirements for weight maintenance in patients with anorexia and bulimia nervosa.
    Weltzin TE; Fernstrom MH; Hansen D; McConaha C; Kaye WH
    Am J Psychiatry; 1991 Dec; 148(12):1675-82. PubMed ID: 1957930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impulsivity and test meal intake among women with bulimia nervosa.
    Sysko R; Ojserkis R; Schebendach J; Evans SM; Hildebrandt T; Walsh BT
    Appetite; 2017 May; 112():1-8. PubMed ID: 28077307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and non-clinical binges.
    Jansen A; van den Hout M; Griez E
    Behav Res Ther; 1990; 28(5):439-44. PubMed ID: 2256903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bulimic vomiting alters pain tolerance and mood.
    Abraham HD; Joseph AB
    Int J Psychiatry Med; 1986-1987; 16(4):311-6. PubMed ID: 3030947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Speed of eating as a determinant of bulimic desire to vomit: a controlled study.
    Azrin NH; Kellen MJ; Ehle CT; Brooks JS
    Behav Modif; 2006 Sep; 30(5):673-80. PubMed ID: 16894235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nasogastric tube feeding in bulimia. Controlled study with follow-up at 3 months].
    Rigaud D; Brayer V; Biton-Jélic V; Païs V; Pennacchio H; Brun JM
    Presse Med; 2007 Oct; 36(10 Pt 1):1354-63. PubMed ID: 17408917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mood changes in bulimia nervosa.
    Johnson-Sabine EC; Wood KH; Wakeling A
    Br J Psychiatry; 1984 Nov; 145():512-6. PubMed ID: 6594179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emotional and somatic consequences of binge episodes.
    Lingswiler VM; Crowther JH; Stephens MA
    Addict Behav; 1989; 14(5):503-11. PubMed ID: 2589128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
    Faris PL; Kim SW; Meller WH; Goodale RL; Oakman SA; Hofbauer RD; Marshall AM; Daughters RS; Banerjee-Stevens D; Eckert ED; Hartman BK
    Lancet; 2000 Mar; 355(9206):792-7. PubMed ID: 10711927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence of bulimia among secondary school students in Casablanca].
    Ghazal N; Agoub M; Moussaoui D; Battas O
    Encephale; 2001; 27(4):338-42. PubMed ID: 11686055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different moderators of cognitive-behavioral therapy on subjective and objective binge eating in bulimia nervosa and binge eating disorder: a three-year follow-up study.
    Castellini G; Mannucci E; Lo Sauro C; Benni L; Lazzeretti L; Ravaldi C; Rotella CM; Faravelli C; Ricca V
    Psychother Psychosom; 2012; 81(1):11-20. PubMed ID: 22116257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between objective and subjective binge eating and psychopathology during a psychological treatment trial for bulimic symptoms.
    Goldschmidt AB; Accurso EC; Crosby RD; Cao L; Ellison J; Smith TL; Klein MH; Mitchell JE; Crow SJ; Wonderlich SA; Peterson CB
    Appetite; 2016 Dec; 107():471-477. PubMed ID: 27554184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.